Innovative therapeutics

Investors

Investor Relations

BioMarin Pharmaceutical Inc. was founded in 1997, and since July 1999 the company's common stock has been traded on the Nasdaq National Market under the ticker symbol BMRN. BioMarin's policy is to fully comply with all rules put forth by the Securities and Exchange Commission and the Nasdaq National Market. For misplaced stock certificates, please contact our transfer agent directly.

img_bottom-content

Diseases

MPS I, MPS VI, PKU, LEMS, Lysosomal Storage Disorders, Morquio A/MPS IVA

Products

VIMIZIM™, Kuvan®, Naglazyme®, Aldurazyme®, Firdapse®

Patient/Physician Contact Information

BioMarin Patient and Physician Support (BPPS)
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: bpps@bmrn.com

Top